Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems
Song-Chou Hsieh,1 Chang-Youh Tsai,2 Chia-Li Yu3 1Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, 2Section of Allergy, Immunology & Rheumatology, Taipei Veterans General Hospital, 3Department of Internal Medicine, Institute...
Guardado en:
Autores principales: | Hsieh SC, Tsai CY, Yu CL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6cac63d5fc884afeb7b42c432419d842 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of refractory lupus nephritis: challenges and solutions
por: Yo JH, et al.
Publicado: (2019) -
Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population
por: Bartels-Peculis L, et al.
Publicado: (2020) -
Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus
por: Huang-Chen Chang, et al.
Publicado: (2021) -
Clinical utility of urinary soluble CD163 in evaluation of lupus nephritis patients
por: Nada M. Gamal, et al.
Publicado: (2022) -
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Claudio Ponticelli, et al.
Publicado: (2021)